CGTX icon

Cognition Therapeutics
CGTX

Overview Fund Activity

31 hedge funds and large institutions have $13.9M invested in Cognition Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 4 closing their positions.

Holders
31
Holders Change
+3
Holders Change %
+10.71%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
8
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PFO
1
Pathstone Family Office
New Jersey
$8.4M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$762K
3
CC
3
Carlson Capital
Texas
$190K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$152K
5
CAPTRUST Financial Advisors
5
CAPTRUST Financial Advisors
North Carolina
$95K

Top Sellers

1
NCM
1
Nantahala Capital Management
Connecticut
$0
2
PM
2
Prosight Management
Texas
$0
3
ACM
3
AIGH Capital Management
Maryland
$1.52M
4
VC
4
Voss Capital
Texas
$416K
5
PWM
5
Perigon Wealth Management
California
$70K
Name Market Value Shares Shares
Change 		Shares
Change %
Northern Trust
26
Northern Trust
Illinois
$27K 14,116 +14,116 New
IA
27
IFP Advisors
Florida
$10K 750 – –
UBS Group
28
UBS Group
Switzerland
$6K 3,185 +2,286 +254%
BCA
29
Bray Capital Advisors
Florida
$4K 2,250 – –
TRCT
30
Tower Research Capital (TRC)
New York
$2K 937 -970 -51%
NCM
31
Nantahala Capital Management
Connecticut
– – -192,752 Closed
PM
32
Prosight Management
Texas
– – -120,198 Closed
BRF
33
B. Riley Financial
California
– – -30,904 Closed
Two Sigma Advisers
34
Two Sigma Advisers
New York
– – -15,600 Closed
CFGS
35
Concourse Financial Group Securities
Alabama
– – – –
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$0 112 +112 New
1
2